Jeff Martin
Stock Analyst at Roth Capital
(3.49)
# 891
Out of 5,072 analysts
63
Total ratings
59.32%
Success rate
16.18%
Average return
Main Sectors:
Stocks Rated by Jeff Martin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PERI Perion Network | Reiterates: Buy | $14 → $15 | $9.94 | +45.88% | 10 | Nov 13, 2025 | |
| NSP Insperity | Maintains: Buy | $85 → $74 | $35.45 | +108.74% | 9 | Aug 4, 2025 | |
| FC Franklin Covey Co. | Maintains: Buy | $30 → $27 | $15.62 | +72.86% | 8 | Jul 7, 2025 | |
| TACT TransAct Technologies | Maintains: Buy | $6 → $5 | $4.57 | +9.53% | 1 | May 14, 2025 | |
| OSIS OSI Systems | Maintains: Buy | $224 → $245 | $271.56 | -9.78% | 16 | May 2, 2025 | |
| BGSF BGSF, Inc. | Maintains: Buy | $12 → $9 | $4.50 | +100.00% | 1 | Mar 20, 2025 | |
| BBSI Barrett Business Services | Maintains: Buy | $43 → $45 | $35.30 | +27.48% | 5 | Nov 7, 2024 | |
| HCKT The Hackett Group | Maintains: Buy | $29 → $30 | $18.40 | +63.04% | 6 | Nov 5, 2024 | |
| BWMN Bowman Consulting Group | Maintains: Buy | $47 → $43 | $36.05 | +19.28% | 5 | Aug 8, 2024 | |
| GLMD Galmed Pharmaceuticals | Initiates: Buy | $5,760 | $0.92 | +623,411.58% | 2 | Nov 15, 2017 |
Perion Network
Nov 13, 2025
Reiterates: Buy
Price Target: $14 → $15
Current: $9.94
Upside: +45.88%
Insperity
Aug 4, 2025
Maintains: Buy
Price Target: $85 → $74
Current: $35.45
Upside: +108.74%
Franklin Covey Co.
Jul 7, 2025
Maintains: Buy
Price Target: $30 → $27
Current: $15.62
Upside: +72.86%
TransAct Technologies
May 14, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $4.57
Upside: +9.53%
OSI Systems
May 2, 2025
Maintains: Buy
Price Target: $224 → $245
Current: $271.56
Upside: -9.78%
BGSF, Inc.
Mar 20, 2025
Maintains: Buy
Price Target: $12 → $9
Current: $4.50
Upside: +100.00%
Barrett Business Services
Nov 7, 2024
Maintains: Buy
Price Target: $43 → $45
Current: $35.30
Upside: +27.48%
The Hackett Group
Nov 5, 2024
Maintains: Buy
Price Target: $29 → $30
Current: $18.40
Upside: +63.04%
Bowman Consulting Group
Aug 8, 2024
Maintains: Buy
Price Target: $47 → $43
Current: $36.05
Upside: +19.28%
Galmed Pharmaceuticals
Nov 15, 2017
Initiates: Buy
Price Target: $5,760
Current: $0.92
Upside: +623,411.58%